Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer D, Phay JE, Holt S, O'Donnell B, Nguyen J, Joseph D, Chi A, Wu S, Hao Y, Huang J, Klopper JP, Kloos RT, Kennedy GC, Shin J.
Whitmer D, et al. Among authors: shin j.
Front Endocrinol (Lausanne). 2022 Dec 22;13:1073592. doi: 10.3389/fendo.2022.1073592. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 36619548
Free PMC article.